Navigating Surgery While on GLP-1 Medications: Can I Take Ozempic After Surgery?

Introduction

Undergoing surgery is a significant life event, often accompanied by a myriad of preparations and considerations. For individuals managing their weight or diabetes with medications like Ozempic, the pre- and post-operative period introduces a unique layer of complexity. Suddenly, questions arise about how these powerful medications interact with anesthesia, recovery, and overall surgical safety. It’s not just about what you eat or drink before a procedure; it’s about understanding the subtle yet crucial ways your body processes medication when facing a surgical intervention. Many people are embarking on health journeys that incorporate advanced medical science, and we believe it’s essential to provide clear, actionable insights to ensure these journeys continue safely and effectively, especially around critical events like surgery.

At TrimRx, our journey began with a shared vision: to help individuals embrace healthier lifestyles by merging cutting-edge telehealth innovations with effective weight loss solutions. We understand that sustainable weight loss should be achieved through science, empathy, and a transparent approach. This commitment extends to providing comprehensive information that empowers you to make informed decisions about your health. This blog post is designed to be your authoritative guide, delving into the intricacies of using GLP-1 receptor agonists, such as Ozempic®, before and after surgery. We will explore the vital reasons behind pausing these medications, the recommended timelines for discontinuation and resumption, and how our personalized, medically supervised programs support your health every step of the way. By the end of this article, you will have a clearer understanding of how to safely navigate your surgical journey while optimizing your long-term health and weight management goals.

Understanding GLP-1 Agonists and Their Mechanism

To truly grasp why adjustments are necessary for medications like Ozempic® around surgery, it’s crucial to first understand what GLP-1 receptor agonists are and how they work within the body. These medications represent a significant advancement in the fields of diabetes management and weight loss, offering powerful tools for improving metabolic health.

What Are GLP-1 Receptor Agonists?

GLP-1 stands for Glucagon-Like Peptide-1, a natural hormone produced in the gut that plays a critical role in regulating blood sugar and appetite. GLP-1 receptor agonists are a class of medications designed to mimic the action of this natural hormone. By activating GLP-1 receptors in the body, they trigger a cascade of beneficial effects.

At TrimRx, we offer a range of these innovative solutions, including branded options like Ozempic®, Mounjaro®, Zepbound®, and Wegovy®, all of which are FDA-approved medications for their respective indications. We also provide highly effective compounded medications such as Compounded Semaglutide, Oral Semaglutide, Compounded Tirzepatide, and Oral Tirzepatide. It’s important to note that while branded medications like Ozempic® and Zepbound® have received FDA approval, compounded medications are provided through FDA-registered, inspected, and approved pharmacies, ensuring the highest standards of quality and safety. To determine your eligibility and receive a personalized treatment plan for these prescription medications, we encourage you to take our free assessment quiz.

The Dual Action of GLP-1s: Blood Sugar Regulation and Gastric Emptying

The effectiveness of GLP-1 agonists stems from their multifaceted impact on the body:

Blood Glucose Control

For individuals with Type 2 diabetes, GLP-1 agonists stimulate insulin release from the pancreas when blood sugar levels are high, and simultaneously reduce glucagon secretion, a hormone that raises blood sugar. This helps to stabilize glucose levels, reducing the risk of hyperglycemia.

Appetite Suppression and Satiety

Beyond blood sugar, GLP-1 agonists profoundly influence appetite. They act on the brain to reduce hunger signals and increase feelings of fullness, leading to decreased caloric intake. This mechanism is a cornerstone of their success in weight management, making them invaluable tools for those seeking sustainable weight loss.

Delayed Gastric Emptying

Perhaps the most critical mechanism when discussing surgery is their effect on gastric emptying. GLP-1 agonists slow down the rate at which food leaves the stomach and moves into the small intestine. This slower digestion contributes to prolonged satiety, better blood sugar control by moderating the post-meal glucose spike, and enhances the overall weight loss effect.

It is this specific action—delayed gastric emptying—that becomes paramount in the context of surgery, particularly when general anesthesia is involved. Understanding this effect is the first step in appreciating the strict pre-operative guidelines that medical professionals now recommend.

The Critical Link: GLP-1s and Anesthesia Risks

The primary concern regarding GLP-1 agonists and surgery revolves around their effect on gastric emptying. While beneficial for weight loss and blood sugar control, this mechanism can introduce significant risks during anesthetic procedures.

The Dangers of Delayed Gastric Emptying

When GLP-1 medications slow down stomach emptying, food and liquids remain in the stomach for a longer duration than usual. This means that even after adhering to standard fasting protocols (typically 8-12 hours without food or drink before surgery), a patient taking a GLP-1 agonist might still have residual stomach contents.

Aspiration Pneumonia: A Major Anesthesia Complication

The presence of food or liquid in the stomach during general anesthesia creates a heightened risk of a serious complication known as aspiration pneumonia. Here’s why this is so critical:

Loss of Protective Reflexes

During general anesthesia, the body’s natural protective reflexes are suppressed. These reflexes include the ability to swallow effectively and to close off the airway (via the epiglottis) to prevent stomach contents from entering the lungs.

Regurgitation and Aspiration

If there is food or liquid in the stomach, and these protective reflexes are compromised, there is an increased chance of regurgitation. This is when stomach contents flow back up into the esophagus and potentially into the pharynx. From there, they can be accidentally inhaled, or “aspirated,” into the trachea and then into the lungs.

Consequences of Aspiration

Aspiration of gastric contents into the lungs can lead to severe pulmonary complications, including:

• Aspiration Pneumonia: A serious infection and inflammation of the lungs caused by the foreign material.
• Acute Respiratory Distress Syndrome (ARDS): A life-threatening lung condition that prevents enough oxygen from getting to the lungs and into the blood.
• Airway Obstruction: In severe cases, large particles of food can physically block the airway, leading to immediate respiratory distress.

Historically, the understanding of aspiration risks was a foundational element in anesthetic practice, leading to the strict fasting guidelines that have been in place for decades. The emergence of GLP-1 agonists and their widespread use has necessitated a re-evaluation of these guidelines for a specific patient population.

Why Standard Fasting Protocols May Not Suffice

For decades, the standard protocol of fasting before surgery has been effective in minimizing aspiration risks. This is because, for most individuals not on GLP-1 agonists, the stomach empties its contents within a predictable timeframe. However, recent research, including studies published in journals like JAMA Surgery, indicates that a significant percentage of patients taking GLP-1 receptor agonists (e.g., 56% in one study) may still have residual stomach contents even after standard fasting periods. This finding underscores that the traditional fasting window may be insufficient for those on these medications, thereby necessitating more cautious and personalized pre-operative guidance.

It is because of these serious, though rare, complications that medical societies, including the American Society of Anesthesiologists (ASA), have issued specific recommendations regarding the discontinuation of GLP-1 medications prior to elective surgical procedures. These guidelines are designed to prioritize patient safety above all else, aligning perfectly with our core values at TrimRx: empathetic, innovative, trustworthy, supportive, results-oriented, and personalized care.

Pre-Surgery Protocols: When to Pause GLP-1 Medications

The decision of when to discontinue GLP-1 receptor agonists before surgery is a critical one, requiring careful consideration and, most importantly, personalized medical advice. While general recommendations exist, the specific timing can vary based on the medication, individual patient factors, and the nature of the surgical procedure.

General Guidelines for Discontinuation

Medical experts and surgical societies have established guidelines to minimize the risk of delayed gastric emptying and aspiration during surgery. The primary recommendation is to pause GLP-1 medications prior to any procedure requiring general anesthesia.

• For Once-Weekly Injections (e.g., Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Compounded Semaglutide, Compounded Tirzepatide): Most experts, including the American Society of Anesthesiologists, suggest discontinuing these medications at least one week (7 days) before elective surgical procedures. Some surgical specialties, particularly plastic surgery practices focused on maximizing safety, may recommend an even longer period, such as two to three weeks prior to surgery, to ensure the medication is entirely out of the system. This longer window accounts for the drug’s half-life, which refers to the time it takes for half of the medication to be eliminated from the body. Given the typically longer half-life of these weekly injectables, a more conservative approach often provides an added layer of safety.
• For Once-Daily Doses (e.g., Oral Semaglutide, Oral Tirzepatide, daily injectables like liraglutide): For medications taken daily, the recommendation is typically to withhold the dose on the morning of surgery. However, even with daily medications, the effects on gastric emptying can persist, and your healthcare provider might advise a slightly longer pause depending on the specific drug and your individual response.

The Importance of Individualized Medical Consultation

It cannot be stressed enough that these are general guidelines. Your personal health status, the type of surgery, and any co-existing medical conditions (such as diabetes) will all influence the specific recommendations provided by your healthcare team.

This is precisely where TrimRx’s commitment to personalized, medically supervised care shines. We understand that every individual’s journey is unique. When you consider our prescription weight loss solutions like Compounded Semaglutide or Ozempic®, the first step is to take our free assessment quiz. This comprehensive evaluation allows our affiliated medical providers to assess your eligibility and create a personalized treatment plan tailored to your specific needs, including guidance on medication management around surgical events. Our approach remains consistent: transparent service that prioritizes your safety and individual well-being.

Before any surgery, it is absolutely essential to:

• Inform your surgeon and anesthesiologist: Disclose all medications you are currently taking, including prescription GLP-1 agonists, over-the-counter supplements like our GLP-1 Daily Support or Weight Loss Boost, and any herbal remedies.
• Discuss a specific discontinuation plan: Work with your medical team to determine the precise timing for pausing your GLP-1 medication. If you manage diabetes with a GLP-1 agonist, your doctor will also advise on alternative diabetes management strategies during the temporary pause to ensure your blood sugar remains controlled.
• Understand potential risks of stopping: While stopping is crucial for surgical safety, there can be temporary impacts on blood sugar control for diabetic patients or a brief return of appetite for those managing weight. Your provider will help you weigh these risks against the much larger risk of surgical complications.

Our dedication to safety is paramount, which is why we partner exclusively with FDA-registered and inspected pharmacies for the shipping of weight loss medications. This ensures that every medication you receive through TrimRx meets rigorous quality and safety standards, providing you with peace of mind as you prepare for any medical procedure.

Navigating the Surgical Journey with GLP-1s

The period surrounding surgery is a delicate balance of careful planning, adherence to medical advice, and vigilant monitoring. For individuals taking GLP-1 agonists, this journey requires an even more focused approach to ensure both surgical safety and continuity of care for your weight management or diabetes treatment.

Before Surgery: A Collaborative Approach

Effective preparation is the cornerstone of a safe surgical outcome. This involves open communication and collaboration with your entire healthcare team, including your primary care physician, surgeon, and anesthesiologist.

Full Disclosure of Medications and Supplements

The first and most crucial step is to provide a comprehensive list of all medications, supplements, and herbal remedies you are currently using. This includes prescription GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, Zepbound®, or our compounded options such as Compounded Semaglutide and Compounded Tirzepatide. It also extends to quick-access supplements like our GLP-1 Daily Support and Weight Loss Boost. Even seemingly innocuous supplements can interact with anesthesia or affect recovery, making full transparency vital. Your honesty allows your care team to develop the safest possible plan tailored to your unique health profile.

Developing a Personalized Pre-Surgical Plan

Based on your disclosed medications and health history, your medical team will create a specific plan for pausing your GLP-1 agonist. This plan will consider:

• Type of GLP-1: Weekly injectables versus daily oral or injectable forms.
• Length of discontinuation: This may range from one week to three weeks or more, as discussed earlier, depending on the specific drug, your individual response, and the surgeon’s preference.
• Management of underlying conditions: If you use GLP-1s for diabetes, your doctor will provide alternative strategies to maintain blood sugar control during the pause, such as temporary insulin adjustments or other oral medications.
• Adjusted fasting instructions: You might receive more stringent or longer fasting instructions than individuals not on GLP-1s, potentially including specific liquid diets leading up to the procedure.

At TrimRx, our comprehensive service includes doctor consultations, medication provided by FDA-registered pharmacies, necessary lab work, and unlimited support. This integrated approach ensures you have continuous guidance throughout your health journey, including critical times like surgical preparation. We pride ourselves on providing compassionate care that respects every individual’s unique journey, combining advanced medical science with modern technology.

During Surgery: Vigilance and Advanced Monitoring

On the day of surgery, the anesthesiologist plays a critical role in ensuring your safety, especially if you have been taking GLP-1 agonists.

Gastric Ultrasonography

In some cases, especially if there’s uncertainty about gastric emptying, the anesthesiologist might perform a gastric ultrasonography. This quick, non-invasive imaging scan helps to visualize the stomach contents and confirm whether it is sufficiently empty before proceeding with anesthesia. This advanced monitoring helps mitigate risks associated with delayed gastric emptying.

Anesthesia Management

Anesthesiologists are highly skilled in adjusting their techniques to minimize aspiration risk. This may include using rapid sequence induction (RSI), a specific method of anesthesia induction designed to secure the airway quickly and prevent aspiration, particularly in patients deemed at higher risk.

After Surgery: Thoughtful Resumption and Recovery

The post-operative period is equally crucial for careful management and successful recovery. The decision of when to restart your GLP-1 medication must be made under the strict guidance of your healthcare provider.

Criteria for Restarting

GLP-1 agonists should only be resumed once specific conditions are met to ensure safety and effective healing:

• Tolerating Oral Intake: You must be able to safely eat and drink without significant nausea, vomiting, or gastrointestinal distress. Your normal gastrointestinal function should have returned.
• Adequate Nutrition for Healing: Surgery places significant demands on your body, requiring ample protein and nutrients for tissue repair and recovery. GLP-1 agonists can suppress appetite, which might hinder your ability to consume enough calories and nutrients essential for healing. Your care team will ensure you are meeting your nutritional needs before resuming the medication.
• Stabilized Condition: Your overall medical condition should be stable, and you should be progressing well in your recovery.

General Timelines for Resumption

While there are no universal strict guidelines, common recommendations for restarting GLP-1 medications range from:

• Two weeks post-op: This is often the minimum timeframe suggested by some plastic surgery practices, allowing for initial healing and the re-establishment of oral intake.
• Four to six weeks post-op: A more conservative approach, particularly for extensive surgeries, may recommend waiting this long. This interval ensures that incisions have had sufficient time to heal, swelling and bruising have significantly subsided, and the body has been properly nourished and hydrated throughout the critical recovery phase.

Ongoing Support and Monitoring

Throughout your recovery, regular communication with your healthcare provider is paramount. They will monitor your progress, address any post-operative concerns, and guide the safe reintroduction of your GLP-1 medication. If you are a TrimRx patient, our team is here to offer unlimited support, helping you navigate these transitions with confidence. We offer compassionate care that respects every individual’s unique journey. Whether it’s answering questions about your medication, supporting your nutritional needs during recovery, or adjusting your personalized plan, we are committed to being a trustworthy partner in your health journey.

Remember, the goal is not just to get through surgery, but to emerge healthier and continue your path toward sustainable well-being. This coordinated, empathetic, and science-backed approach is central to how we empower individuals at TrimRx.

Latest Research and Evolving Guidelines

The field of medicine is constantly evolving, and the guidelines surrounding GLP-1 receptor agonists and surgery are no exception. Recent research continues to shed light on the nuances of these medications, shaping how healthcare providers approach pre- and post-operative care.

Key Research Findings

Several studies have contributed valuable insights into the interaction between GLP-1s and surgical outcomes:

Residual Gastric Content Studies

A significant body of research has confirmed that patients taking GLP-1 receptor agonists frequently have increased residual gastric content, even after prolonged fasting periods. For instance, a prospective observational study published in Anaesthesia used gastric ultrasound to demonstrate a clear relationship between peri-operative semaglutide use and higher residual gastric volume. This provides objective evidence for the increased risk of aspiration if GLP-1s are not appropriately managed before surgery. Another study in JAMA Surgery highlighted that a substantial percentage of GLP-1 users had residual stomach contents, reinforcing the need for revised fasting protocols.

Aspiration Risk Re-evaluation

While the delayed gastric emptying is well-established, the direct link to a significant increase in aspiration pneumonia has been a subject of ongoing investigation. A large cohort study examined the risk of postoperative complications, including aspiration pneumonia, among patients using GLP-1 RAs before surgery. Interestingly, while GLP-1 RA use was associated with a higher risk of delayed gastric emptying, the study did not find a statistically significant increase in the risk of postoperative aspiration pneumonia compared to patients not using these medications. This nuance suggests that while the mechanism for risk is present, the ultimate clinical outcome of aspiration pneumonia may not be as universally elevated as initially feared across all surgical contexts. However, the presence of delayed emptying still represents a potential hazard that justifies precautionary measures.

Evolving Anesthesia Society Recommendations

In response to these findings and anecdotal reports, prominent organizations like the American Society of Anesthesiologists (ASA) have released and continually updated their guidance for managing GLP-1 agonists around surgery. Initially, recommendations leaned towards a conservative 7-day discontinuation. More recent multi-society guidance has provided more refined perspectives, acknowledging the complexities. These guidelines emphasize the importance of individual patient risk assessment, open communication between patients and their care teams, and the potential for tools like gastric ultrasound to guide real-time decisions on the day of surgery. This evolving understanding highlights a shift towards more nuanced, patient-specific approaches rather than blanket recommendations.

Implications for Practice and Patient Care

The ongoing research reinforces several key principles for both patients and healthcare providers:

• Heightened Awareness: There is increased awareness within the medical community about the unique challenges posed by GLP-1 medications during the peri-operative period.
• Personalized Assessment: The emphasis is increasingly on personalized risk assessment. Factors such as the specific GLP-1 drug, its dosage, the patient’s comorbidities (e.g., gastroparesis), and the type of surgery (e.g., emergency vs. elective) all play a role in determining the safest course of action.
• Patient Education: Patients need to be thoroughly educated about the risks and the rationale behind pre-operative instructions. This empowers them to be active participants in their safety.
• Technological Integration: The use of gastric ultrasonography as a pre-operative screening tool is gaining traction, providing an objective measure of stomach contents on the day of surgery.

At TrimRx, we stay abreast of these critical developments and integrate the latest scientific understanding into our patient care protocols. Our team is committed to delivering solutions that are not only effective for weight loss but also rigorously safe. We champion a science-backed approach, ensuring that our recommendations are informed by the most current research and clinical best practices. This ensures that when you engage with us, whether through our free assessment quiz for a personalized prescription plan or by exploring our GLP-1 Daily Support or Weight Loss Boost, you are receiving care aligned with the forefront of medical knowledge.

TrimRx’s Approach to Safe and Personalized Weight Loss

At TrimRx, we recognize that true well-being extends beyond just numbers on a scale. It’s about empowering individuals to embrace healthier lifestyles through a supportive, science-driven, and highly personalized approach. Our foundational belief is that sustainable weight loss should be achieved through science, empathy, and transparent communication, guiding every aspect of our service.

Our Story and Values in Action

Our journey began with a shared vision to merge cutting-edge telehealth innovations with effective weight loss solutions, making personalized, medically supervised care accessible and convenient. We built our platform to be a user-friendly and supportive space where individuals receive care designed to make sustainable weight loss attainable and tailored to their unique circumstances. This ethos is particularly relevant when navigating complex health scenarios like surgery.

We embody a brand personality that is empathetic, innovative, trustworthy, supportive, results-oriented, and personalized. These aren’t just words; they are the pillars upon which we deliver compassionate care that respects every individual’s journey. By combining advanced medical science with modern technology, we ensure that you receive the best possible support, whether you’re just starting your weight loss journey or managing specific health considerations around surgery.

Comprehensive and Transparent Service

Our commitment to transparent service means that our approach remains consistent, regardless of dosage changes or specific medications. We believe you deserve to understand every step of your treatment. When you choose TrimRx for your weight loss journey, our comprehensive service package includes:

• Doctor Consultations: Expert medical guidance to understand your health needs and establish a personalized treatment plan.
• Medication: Access to clinically proven GLP-1 medications, including branded Ozempic®, Mounjaro®, Zepbound®, Wegovy®, and our high-quality compounded options like Compounded Semaglutide, Oral Semaglutide, Compounded Tirzepatide, and Oral Tirzepatide. We emphasize that branded medications like Ozempic® and Zepbound® are FDA-approved. Our compounded medications are sourced exclusively from FDA-registered, inspected, and approved pharmacies, ensuring the highest standards of safety and quality.
• Lab Work: Necessary diagnostic tests to inform your treatment plan and monitor your progress.
• Unlimited Support: Our dedicated team is always available to answer your questions, provide encouragement, and offer guidance throughout your journey.
• Shipping: Convenient delivery of your medications directly to your door, with no hidden fees.

Your Personalized Path to Wellness

We understand that a truly effective weight loss program is one that adapts to you. This adaptability is central to our offerings:

• Prescription Weight Loss Program (Requiring the Quiz): For those seeking the powerful benefits of GLP-1 medications, we invite you to take our free assessment quiz. This personalized assessment helps our affiliated medical providers determine your eligibility and craft a tailored treatment plan that aligns with your health goals and any specific medical considerations, such as upcoming surgery.
• Quick-Access Supplements (No Quiz Required): To support overall wellness and complement your weight loss journey, we also offer immediate support supplements:
  • GLP-1 Daily Support: Designed to provide daily assistance for your metabolic health.
  • Weight Loss Boost: Formulated to enhance your body’s natural weight management processes.

Whether you’re exploring the possibility of a prescription medication or seeking immediate support for your health goals, TrimRx is here to provide solutions that are safe, effective, and uniquely yours. We believe in empowering you with knowledge and support, ensuring you can confidently navigate every aspect of your health journey, including significant events like surgery.

Conclusion

The journey toward better health is deeply personal, often marked by triumphs, challenges, and moments requiring careful consideration, such as navigating surgery while on powerful medications like Ozempic® and other GLP-1 receptor agonists. We’ve explored the intricate mechanisms of these medications, the critical risks associated with delayed gastric emptying during anesthesia, and the paramount importance of precise pre- and post-operative planning. The consensus from leading medical bodies and recent research underscores that pausing GLP-1 medications for an appropriate duration before surgery is a vital safety measure to prevent serious complications like aspiration pneumonia.

This detailed understanding reinforces a fundamental truth: your health journey should always be guided by science, empathy, and personalized medical supervision. At TrimRx, these principles are at the heart of everything we do. Our commitment to providing transparent, supportive, and effective weight loss solutions means we partner with you to navigate every step, ensuring safety and optimizing outcomes. From expert doctor consultations to medication provided by FDA-registered and inspected pharmacies, comprehensive lab work, and unlimited support, we are dedicated to making sustainable weight loss attainable and tailored to your individual needs.

As you plan for any surgical procedure, remember that open and honest communication with your entire healthcare team is non-negotiable. Disclose all medications, including any GLP-1 agonists or our GLP-1 Daily Support and Weight Loss Boost supplements. Allow your medical providers to create a personalized plan for pausing and restarting your medication, ensuring your safety during surgery and supporting your recovery.

If you’re considering how our personalized, medically supervised weight loss programs can support your overall health and well-being, especially as you anticipate or recover from surgery, we invite you to take the next step. Discover if you qualify for our prescription weight loss medications by taking our free assessment quiz today. Together, we can ensure your path to a healthier life is safe, effective, and uniquely yours.

FAQ

Q1: When exactly should I stop Ozempic or similar GLP-1 medications before surgery?

A1: While recommendations vary, the general guideline for once-weekly GLP-1 injections (like Ozempic®) is to stop them at least one week (7 days) before an elective surgical procedure. However, some healthcare providers, especially for certain surgeries, may recommend pausing the medication for two to three weeks to ensure it’s entirely out of your system. For daily doses, you typically withhold the medication on the morning of surgery. Always consult your surgeon and anesthesiologist for specific, personalized instructions tailored to your health and the type of surgery.

Q2: What are the main risks of taking Ozempic too close to surgery?

A2: The primary risk is delayed gastric emptying, meaning food and liquids remain in your stomach longer than usual. Under general anesthesia, your body’s protective reflexes are suppressed, increasing the risk of aspiration pneumonia. This severe complication occurs if stomach contents are regurgitated and accidentally inhaled into the lungs, potentially leading to serious respiratory issues. Ensuring an empty stomach before anesthesia is critical for patient safety.

Q3: How soon can I restart Ozempic or other GLP-1 medications after surgery?

A3: Restarting GLP-1 medications after surgery should only occur under the strict guidance of your healthcare provider. Generally, you must be able to safely tolerate oral intake (eating and drinking) without significant nausea or vomiting, and your normal gastrointestinal function should have returned. Timelines vary, with some recommendations suggesting waiting at least two weeks post-op, while others advise a more conservative approach of four to six weeks to allow for comprehensive healing and nutritional recovery. Your doctor will assess your individual recovery progress before giving clearance.

Q4: Does TrimRx offer alternatives or support during the period I need to pause my GLP-1 medication for surgery?

A4: Yes, TrimRx is committed to supporting your health journey at every stage. During a temporary pause of your prescription GLP-1 medication for surgery, our affiliated medical providers can help discuss strategies to manage your blood sugar if you have diabetes, or support appetite control. Additionally, you can explore our quick-access supplements like GLP-1 Daily Support and Weight Loss Boost. Our comprehensive service includes unlimited support, ensuring you have continuous guidance and care from our team throughout your pre- and post-operative periods.